Gluten Intolerance Treatment Market Trends

Growth Drivers

• Growing Prevalence of Autoimmune, Allergic, and Non-autoimmune-allergic GRDs – such as dermatitis herpetiformis (DH), celiac diseases, gluten ataxia (GA), wheat allergy (WA), and non-celiac gluten sensitivity (NCGS). As per some studies potentially over 41% of all people with ataxia of unknown origin may have gluten ataxia.
• Rising Damage of Gut Flora or Dysbiosis – owing to the high usage of antibiotics or consuming food that they can’t digest. Gluten which is a protein is commonly found in wheat, barley, and other grains. Their increasing presence in a lot of processed foods and drinks, including pasta, cereal, and beer, and in things like vitamins, cosmetics, and even certain medications is responsible for the widespread gluten intolerance nowadays. In the United States, nearly 6% of the population is gluten intolerant.
• Increasing Research & Development – an international research team from Italy and France uncovered a new molecular player in the development of gluten intolerance. The discovery that is published in The EMBO Journal, suggests potential targets for the development of therapeutic approaches for the disease.

Challenges

• Challenge Associated with Diagnosis – the same clinical manifestations for different GRDs that have specific pathophysiological responses to the ingestion of gluten can make their differential diagnosis challenging which is considered a major factor affecting the market growth.
• Lack of Awareness
• Need for Customized Treatment